Summary by Moomoo AI
Shattuck Labs, Inc., a biotechnology company, has been informed by the United States Securities and Exchange Commission (SEC) that its registration statement on Form S-3, filed on January 24, 2024, will not undergo review. The SEC's communication, dated January 30, 2024, was addressed to Dr. Taylor Schreiber, the Chief Executive Officer of Shattuck Labs. The SEC's letter referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures, regardless of the SEC's level of review or lack thereof. The SEC provided contact information for further inquiries, directing questions to Cindy Polynice.